With Brock’s vaccine mandate going into effect Tuesday, Sept. 7, the University’s rapid antigen screening program is now also fully underway.

In order to come onto campus without any testing requirements, all Brock students, faculty, staff and visitors will need to be fully vaccinated.

Those who meet specific and limited medical or human rights accommodation criteria will be subject to ongoing rapid antigen screening.

Anyone who is partially vaccinated (has a first dose and awaiting their second dose by Sept. 28) will be subject to rapid antigen screening until 14 days after the second dose.

Brock University is a member of the Creative Destruction Lab (CDL) Rapid Screening Consortium, which is a private sector-led, not-for-profit initiative formed in August 2020.

Before coming to campus, anyone taking part in the program will undergo twice-weekly, at-home COVID-19 rapid antigen screening and results will be provided within 15 minutes of sample collection. Results will be de-identified and uploaded to Health Canada through a dedicated computer or mobile application.

The program uses the Abbott Panbio COVID-19 Rapid Antigen Nasal Test devices, which are available in boxes of 25 units at no charge to students, faculty and staff who qualify for the program.

Instructions on how to arrange for pickup on campus will be sent to those whose exemption or partial vaccine documentation has been uploaded through the Vaccination Declaration Form and verified. Alternative arrangements for pickup can made using the Brock University Rapid Antigen Screening app, which is now available through Microsoft Power Apps.

For more information about the rapid antigen program including frequently asked questions and detailed instructions on how to use the screening kits and the accompanying smart phone app to upload results, visit brocku.ca/coronavirus/rapid-antigen-screening

Anyone with questions about the program should contact rapidantigen@brocku.ca